Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Financial Statements Detail - Accrued and other liabilities (Details)

v3.4.0.3
Condensed Consolidated Financial Statements Detail - Accrued and other liabilities (Details) - USD ($)
$ in Thousands
Mar. 31, 2016
Dec. 31, 2015
Accrued and other liabilities [Abstract]    
Accrued payroll and other benefits $ 1,573 $ 2,156
Deferred rent 724 608
Accrued clinical trial costs 517 406
Accrued legal and accounting fees 511 517
Accrued incentive compensation 243 2,609
Accrued restructuring costs 138 459
Other 681 270
Total $ 4,387 $ 7,025 [1]
[1] The condensed consolidated balance sheet as of December 31, 2015 has been derived from the audited consolidated financial statements as of that date included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2015.